Alberto Molano, PhD,  —

Healx and Boehringer Ingelheim are partnering to speed up the discovery of new treatments for rare neurological diseases such as fragile X syndrome. Under the agreement, Healx’s artificial intelligence (AI) drug discovery platform, called Healnet, will be used in the identification of new indications for products in…

A new case report described a characteristic imaging pattern of fragile X‑associated tremor/ataxia syndrome (FXTAS) in a 63-year-old man, which included white matter lesions in a brain region called the cerebellum. The study, “MRI findings in fragile X‑associated tremor/ataxia syndrome,” was published in the journal…

The proportion of young patients with fragile X syndrome who meet basic recommendations for preventive care varies depending on their health condition and demographics, according to a recent study. The study, “Preventive Care Services and Health Behaviors in Children with Fragile X Syndrome,” was published in the…